Varicella (ICD-11: 1E90) - Complete Clinical Coding Guide

1. Introduction

Varicella is a highly contagious viral disease caused by varicella-zoster virus (VZV), a member of the Herpesviridae family. Characterized by disseminated vesicular eruptions and fever, this condition represents an important public health challenge worldwide, especially in unvaccinated pediatric populations. Transmission occurs primarily through inhalation of infected respiratory secretions or direct contact with vesicular fluid, making the disease extremely transmissible in community and institutional settings.

The clinical importance of varicella transcends its typical benign presentation in healthy children. Although most pediatric cases evolve without serious complications, the disease can present significant consequences in vulnerable populations, including newborns, adults, pregnant women, and immunocompromised individuals. Potential complications include secondary bacterial skin infections, pneumonia, encephalitis, Reye syndrome, and in rare cases, severe hemorrhagic manifestations.

From an epidemiological perspective, varicella remains endemic in regions where universal vaccination has not been implemented, with characteristic seasonal peaks during colder months. The introduction of vaccination programs has demonstrated significant impact in reducing the incidence, hospitalizations, and mortality associated with the disease.

Accurate coding of varicella using the ICD-11 code 1E90 is fundamental for adequate epidemiological surveillance, public health resource planning, analysis of vaccination program effectiveness, and appropriate outbreak management. Correct documentation enables tracking of temporal trends, identification of at-risk groups, and evaluation of the impact of preventive interventions, while also ensuring appropriate reimbursement in health systems and facilitating clinical research on this condition.

2. Correct ICD-11 Code

Code: 1E90

Description: Varicella

Parent category: Varicella zoster virus infections

Official definition: Disease caused by an infection with varicella zoster virus. This disease is characterized by vesicular rash and fever. Transmission is through inhalation of infected respiratory secretions or direct contact with fluid from vesicles.

Code 1E90 specifically represents primary infection with varicella-zoster virus, clearly distinguishing itself from viral reactivation that characterizes herpes zoster. This classification in ICD-11 reflects modern understanding of viral pathogenesis, where first contact with VZV results in varicella, while reactivation of latent virus in nerve ganglia produces completely different clinical manifestations.

The hierarchical structure of ICD-11 positions varicella within the grouping of varicella-zoster virus infections, facilitating integrated epidemiological analysis of all manifestations of this pathogen. This organization allows healthcare professionals and researchers to quickly understand the relationships between different clinical presentations of the same etiological agent.

Appropriate coding requires diagnostic confirmation based on characteristic clinical criteria, and may be complemented by laboratory tests when necessary. Documentation must include elements that unequivocally justify the diagnosis of primary varicella, differentiating it from other vesicular conditions and herpes zoster.

3. When to Use This Code

The code 1E90 should be applied in specific clinical situations that characterize primary infection by varicella-zoster virus:

Scenario 1: Child with generalized vesicular rash A previously healthy five-year-old child presents with recent-onset fever, malaise, and characteristic skin rash. The lesions began as erythematous macules that rapidly evolved to papules and subsequently vesicles with clear liquid content, distributed predominantly on the trunk and face. Examination reveals lesions at different evolutionary stages simultaneously (regional polymorphism), including macules, papules, vesicles, and crusts. Epidemiological history reveals contact with a confirmed case of varicella in a school setting two weeks prior. This classic presentation fully justifies the use of code 1E90.

Scenario 2: Unvaccinated adult with varicella A 28-year-old adult patient with no prior history of varicella or vaccination presents with high fever, intense headache, and disseminated vesicular rash. The lesions are more numerous and confluent than typically observed in children, with significant involvement of oral and genital mucosae. The patient reports exposure to a child with recently diagnosed varicella. Despite the more severe presentation commonly seen in adults, the diagnosis remains primary varicella, coded as 1E90, and may require additional codes for specific complications if present.

Scenario 3: Pregnant woman with primary varicella-zoster infection A woman in the second trimester of pregnancy develops prodromal symptoms followed by typical vesicular rash. Diagnostic confirmation is critical in this context due to fetal and maternal risks. Code 1E90 is appropriate for documenting maternal infection, with additional codes for pregnancy and potential obstetric complications as needed. Detailed documentation is essential for appropriate monitoring and fetal follow-up planning.

Scenario 4: Immunocompromised patient with varicella An individual on immunosuppressive therapy for renal transplant develops varicella following hospital exposure. The lesions present with atypical evolution with hemorrhagic vesicles and prolonged dissemination. Although the presentation is modified by immunologic status, this is primary VZV infection, justifying code 1E90, complemented by codes for immunosuppression and specific complications.

Scenario 5: Confirmed institutional outbreak During epidemiological investigation of an outbreak in a pediatric institution, multiple children develop clinical presentation compatible with varicella at a time interval consistent with person-to-person transmission. Laboratory confirmation by PCR in index cases validates clinical diagnosis in subsequent cases. All confirmed cases should be coded as 1E90 for adequate outbreak documentation.

Scenario 6: Congenital varicella A newborn whose mother developed varicella in the final days before delivery presents with vesicular lesions within the first 48 hours of life. This presentation represents vertical transmission of the virus during the period of maximum maternal viremia, characterizing early neonatal varicella. Code 1E90 is appropriate, complemented by specific codes for neonatal conditions and maternal exposure when applicable.

4. When NOT to Use This Code

Diagnostic accuracy requires clear understanding of situations where code 1E90 is not appropriate:

Herpes zoster (code 1E91): Reactivation of latent varicella-zoster virus in nerve ganglia produces clinical manifestations completely different from primary infection. Herpes zoster is characterized by unilateral vesicular eruption following specific dermatomal distribution, usually accompanied by significant neuropathic pain. Even though the etiologic agent is the same virus, the pathophysiology, clinical presentation, epidemiology, and therapeutic implications are distinct, requiring separate coding.

Other viral vesicular eruptions: Various conditions can clinically mimic varicella. Hand-foot-and-mouth disease caused by enterovirus presents vesicles with characteristic distribution on extremities and oral cavity, but without the regional polymorphism typical of varicella. Disseminated herpes simplex, although vesicular, usually presents grouped lesions and can be differentiated by specific virologic tests. Monkeypox may present with similar lesions, but with synchronized evolution and distinct epidemiologic characteristics.

Drug-induced cutaneous reactions: Some adverse drug reactions can produce vesicular or bullous lesions that superficially resemble varicella. Stevens-Johnson syndrome and toxic epidermal necrolysis, although severe and bullous, present completely different histologic and evolutionary characteristics, requiring specific codes for drug reactions.

Autoimmune bullous dermatoses: Conditions such as bullous pemphigoid or dermatitis herpetiformis may present with vesicles and bullae, but the distribution, chronology, and histopathologic findings allow clear differentiation from varicella.

Post-vaccination eruptions: Individuals who receive live attenuated varicella vaccine may develop mild vesicular eruption as a vaccine reaction. This situation requires specific coding as a reaction to immunization, not as varicella proper, although the agent is the same virus in attenuated form.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

Diagnostic confirmation of varicella is based primarily on characteristic clinical criteria. The typical presentation includes a prodromal period of one to two days with fever, malaise, headache, and anorexia, followed by the appearance of characteristic rash. Lesions begin as erythematous macules that rapidly evolve into papules and subsequently vesicles with clear liquid content ("dewdrops on rose petals"). Regional polymorphism, with lesions in different evolutionary stages present simultaneously, is pathognomonic for varicella.

Centripetal distribution, with greater concentration of lesions on the trunk, face, and scalp, complements the clinical diagnosis. Epidemiological history of exposure to a confirmed case during the typical incubation period (10 to 21 days, most commonly 14 to 16 days) significantly strengthens diagnostic suspicion.

Laboratory confirmation can be obtained through direct methods such as PCR for detection of viral DNA in vesicular fluid, direct immunofluorescence, or viral culture. Serological methods detecting specific IgM or IgG seroconversion can confirm acute infection, although they are less commonly used in routine clinical practice due to the characteristic clinical presentation of the disease.

Step 2: Verify specifiers

Coding with 1E90 captures the diagnosis of varicella, but additional documentation should include important specifiers for clinical and epidemiological management. Severity should be characterized as uncomplicated, moderate, or severe, based on the extent of the rash, systemic symptoms, and presence of complications.

Specific complications require appropriate additional coding. Secondary bacterial skin infections (cellulitis, abscess, necrotizing fasciitis) are common complications, especially in children. Varicella pneumonia, more frequent in adults and immunocompromised individuals, represents a potentially serious complication. Neurological manifestations including encephalitis, cerebellar ataxia, and aseptic meningitis should be documented with specific codes.

Disease duration, previous vaccination status, predisposing conditions (immunosuppression, pregnancy, extreme age), and need for hospitalization should be clearly recorded for complete case characterization.

Step 3: Differentiate from other codes

1E91: Herpes zoster - The fundamental differentiation is based on pathophysiology and clinical presentation. While 1E90 represents primary infection with disseminated and polymorphic rash, code 1E91 is reserved for viral reactivation characterized by unilateral vesicular rash following dermatomal distribution, usually accompanied by significant neuropathic pain. Previous history of varicella or vaccination, patient age (herpes zoster is rare in healthy children), and rash characteristics allow clear distinction.

Other codes within the spectrum of exanthematous viral infections should be considered in the differential diagnosis, but specific clinical and epidemiological characteristics generally allow adequate differentiation.

Step 4: Required documentation

Checklist of mandatory information for adequate coding:

Clinical presentation: Detailed description of the rash including morphology, distribution, evolutionary stages, and regional polymorphism
Chronology: Date of onset of prodromal symptoms and appearance of rash
Epidemiological history: Known exposure to confirmed case, interval since exposure, occurrence of related cases
Vaccination status: History of varicella vaccination, number of doses and dates if available
Systemic symptoms: Fever (pattern and magnitude), malaise, respiratory symptoms, other associated symptoms
Complications: Presence and nature of any complication (secondary infections, pneumonia, neurological manifestations)
Predisposing conditions: Immunosuppression, pregnancy, age, relevant comorbidities
Laboratory confirmation: Results of diagnostic tests if performed (PCR, serology, culture)
Treatment instituted: Antiviral therapy, antibiotics for complications, supportive measures
Clinical course: Response to treatment, disease duration, need for hospitalization

6. Complete Practical Example

Clinical Case

A 7-year-old female patient, previously healthy, presents to the health unit accompanied by her parents with a complaint of fever and "small bumps all over the body" for two days. The parents report that the child attends regular school and that several classmates developed a similar condition over the past three weeks.

Initial presentation: The child appears in good general condition, well-hydrated, febrile (axillary temperature 38.2°C). She reports mild headache and decreased appetite over the past two days. She denies cough, dyspnea, or other significant respiratory symptoms.

Physical examination: On dermatological examination, approximately 50 cutaneous lesions are observed distributed predominantly on the trunk, face, and scalp, with lower density on the extremities. The lesions are in different evolutionary stages: some are recent erythematous macules, others are papules, several present as vesicles with clear liquid content on an erythematous base, and some older lesions have already begun to form crusts. Regional pleomorphism is evident. There are no signs of secondary bacterial infection. Oral mucosa shows two small ulcerated lesions. Cardiopulmonary auscultation without abnormalities. Abdomen without visceromegaly.

Complementary history: Review of the vaccination card reveals that the child did not receive varicella vaccine (not available in the local schedule when she was at the recommended age). Parents deny previous history of varicella. The mother reports that she was informed by the school about cases of "chickenpox" in her daughter's class approximately 15 days ago.

Assessment performed: Based on the characteristic clinical presentation, compatible epidemiological history, and absence of warning signs, the clinical diagnosis of uncomplicated varicella was established without the need for laboratory confirmation.

Diagnostic reasoning: The combination of fever, mild prodromal symptoms, vesicular eruption with regional pleomorphism, characteristic centripetal distribution, and history of exposure during a compatible incubation period establishes a high-confidence diagnosis for varicella. The absence of previous vaccination and history of prior disease makes this presentation consistent with primary infection by varicella-zoster virus.

Step-by-Step Coding

Criteria analysis:

Presence of characteristic vesicular eruption: ✓
Regional pleomorphism (lesions in multiple stages): ✓
Typical centripetal distribution: ✓
Fever and systemic symptoms: ✓
Epidemiological history of exposure: ✓
Absence of previous vaccination: ✓
Absence of prior varicella history: ✓
Compatible incubation period (approximately 15 days): ✓

Code selected: 1E90 - Varicella

Complete justification: Code 1E90 is appropriate because all diagnostic criteria for varicella are present. This is a primary infection by varicella-zoster virus in an unvaccinated patient, manifesting with typical clinical presentation. The distribution of lesions, regional pleomorphism, chronology of evolution, and epidemiological context confirm the diagnosis. There is no evidence of complications requiring additional coding at this time.

Complementary codes: No additional codes are necessary in this case of uncomplicated varicella. If the patient developed complications such as secondary bacterial infection or pneumonia, appropriate additional codes should be included.

Final documentation: "Seven-year-old female patient with diagnosis of varicella (ICD-11: 1E90) characterized by polymorphic vesicular eruption with centripetal distribution, fever, and mild systemic symptoms. History of exposure in school environment 15 days ago. Previously unvaccinated. Uncomplicated condition. Home care instructions provided including isolation, comfort measures, and warning signs for return visit."

7. Related Codes and Differentiation

Within the Same Category

1E91: Herpes zoster

The differentiation between varicella (1E90) and herpes zoster (1E91) is fundamental and is based on distinct clinical, epidemiological, and pathophysiological characteristics.

When to use 1E90 (Varicella):

Primary infection by varicella-zoster virus
Bilateral disseminated vesicular eruption
Regional polymorphism with lesions in multiple evolutionary stages
Centripetal distribution (trunk, face, scalp predominantly)
Generally occurs in unvaccinated children
Recent transmission through contact with active case
Absence of previous history of varicella

When to use 1E91 (Herpes zoster):

Reactivation of latent virus in nerve ganglia
Unilateral vesicular eruption following specific dermatome
Lesions in similar evolutionary stage (monomorphism)
Significant neuropathic pain frequently preceding eruption
More common in adults and elderly
Occurs in individuals with previous history of varicella or vaccination
Does not require recent exposure to active case

Main difference: Varicella represents the organism's first encounter with varicella-zoster virus, resulting in systemic disease with disseminated eruption. Herpes zoster is a manifestation of viral reactivation in a previously infected individual, characterized by localized eruption following specific nerve distribution. The pathophysiology, clinical presentation, affected population, typical complications, and therapeutic approach differ significantly between the two conditions.

Differential Diagnoses

Enterovirus infections (hand-foot-mouth disease): Characterized by vesicles on palms, soles, and oral cavity, with distribution distinct from varicella. Lesions tend to be less numerous and without the characteristic polymorphism.

Disseminated herpes simplex: Grouped vesicular lesions, generally with more localized distribution initially. History of recurrent lesions and laboratory confirmation differentiating HSV from VZV establish the diagnosis.

Bullous impetigo: Staphylococcal bacterial infection producing fragile bullae that rapidly rupture, forming meliceric crusts. Absence of significant fever and systemic symptoms, in addition to lesion characteristics, allow for differentiation.

Drug eruptions: History of recent medication introduction, absence of typical prodromal symptoms of viral infection, and different evolution of lesions guide alternative diagnosis.

8. Differences with ICD-10

In the International Classification of Diseases - 10th Revision (ICD-10), varicella was coded as B01, with subdivisions for specific complications (B01.0 for varicella meningitis, B01.1 for encephalitis, B01.2 for pneumonia, B01.8 for other complications, and B01.9 for varicella without complication).

The transition to ICD-11 with the code 1E90 represents an evolution in the classification structure, reflecting advances in disease understanding and the needs of modern health information systems. The alphanumeric structure of ICD-11 allows greater flexibility and expansion capacity compared to the ICD-10 system.

Main changes:

More flexible coding system allowing post-coordinated specifiers for additional clinical features
Clearer hierarchical structure grouping varicella-zoster infections
Enhanced ability to link codes for more precise documentation of complications and coexisting conditions
Improved compatibility with electronic health systems and digital medical records

Practical impact: The change requires updating information systems, training of coding professionals, and adaptation of institutional protocols. However, the more logical and flexible structure of ICD-11 facilitates more precise documentation, more sophisticated epidemiological analyses, and better interoperability between different health systems globally. Professionals should familiarize themselves with the new coding to ensure adequate transition and continuity in the quality of epidemiological data.

9. Frequently Asked Questions

1. How is chickenpox diagnosed?

Chickenpox diagnosis is primarily clinical, based on the characteristic presentation of polymorphic vesicular eruption with centripetal distribution, accompanied by fever and systemic symptoms. Regional polymorphism, with lesions in different evolutionary stages present simultaneously, is highly suggestive. Epidemiological history of exposure to a confirmed case during the typical incubation period strengthens the diagnosis. Laboratory confirmation through PCR for detection of viral DNA in vesicular fluid, direct immunofluorescence, or serology can be performed in atypical cases, immunocompromised patients, or for confirmation in specific epidemiological contexts, but is generally not necessary in typical cases.

2. Is treatment available in public health systems?

Chickenpox management includes supportive measures and, in specific situations, antiviral therapy. Supportive measures such as fever control with appropriate antipyretics, adequate hydration, and local care to prevent secondary infections are universally available and constitute the cornerstone of treatment in uncomplicated cases. Antiviral therapy with acyclovir is recommended for at-risk groups including adolescents, adults, pregnant women, newborns, and immunocompromised patients. The availability of antivirals in public health systems varies globally, but is generally assured for cases with established medical indication, especially in situations with higher risk of complications.

3. How long does treatment last?

In uncomplicated cases, chickenpox is self-limited, with typical progression of 7 to 10 days from eruption onset until complete crust formation. Supportive measures are maintained throughout this period. When indicated, antiviral therapy with acyclovir is administered for 5 to 7 days, being most effective when initiated within the first 24 to 72 hours after eruption appearance. Isolation should be maintained until all lesions are in the crust phase, generally 5 to 7 days after eruption onset, as the patient remains contagious while active vesicular lesions are present.

4. Can this code be used in medical certificates?

Yes, the ICD-11 code 1E90 can and should be used in medical certificates when appropriate. Chickenpox justifies absence from school activities, work, or other collective activities due to high contagiousness and need for isolation. The recommended absence period extends until all lesions are in the crust phase, generally 5 to 7 days after eruption onset. Proper documentation with the appropriate ICD code ensures formal justification for absence, being accepted by educational institutions, employers, and social security systems. In cases with complications, the absence period may be extended as needed, with appropriate documentation of additional conditions.

5. Is chickenpox more severe in adults than in children?

Yes, chickenpox in adults typically presents with more severe progression compared to healthy children. Adults frequently develop more extensive and confluent eruption, higher fever, and more intense systemic symptoms. The incidence of complications, particularly varicella pneumonia, is significantly higher in adults. Hospitalization and mortality rates are also substantially elevated in this population. Pregnant women represent a particular at-risk group, with higher probability of severe pneumonia and specific fetal risks. These factors justify more frequent consideration of antiviral therapy in adults with chickenpox, even in the absence of other predisposing conditions.

6. Can vaccinated people develop chickenpox?

Yes, although less common, vaccinated individuals can develop chickenpox, a condition known as "breakthrough varicella." This presentation is generally milder, with fewer lesions (often fewer than 50), less intense fever, and faster progression. Lesions may be predominantly maculopapular with fewer typical vesicles. Despite the attenuated presentation, these cases are still contagious and require appropriate isolation. Vaccination, even when it does not completely prevent infection, significantly reduces disease severity and the risk of complications.

7. When should emergency care be sought?

Warning signs indicating need for urgent medical evaluation include: respiratory difficulty or rapid breathing suggesting pneumonia; neurological changes such as mental confusion, excessive drowsiness, seizures, or gait disturbances indicating possible encephalitis or cerebellar ataxia; signs of severe secondary bacterial infection such as extensive areas of erythema, edema, local warmth, intense pain, or persistent fever after initial improvement; hemorrhagic lesions or abnormal bleeding; persistent vomiting or dehydration; and any clinical deterioration in at-risk group patients (immunocompromised, pregnant women, newborns). Early identification of complications and appropriate intervention are fundamental to prevent adverse outcomes.

8. How to prevent chickenpox transmission?

Vaccination represents the most effective preventive measure, with universal immunization programs demonstrating dramatic reduction in disease incidence. For unvaccinated individuals exposed to active cases, isolation of the infected patient until all lesions are in the crust phase is fundamental. Chickenpox is highly contagious, with transmission via airborne and direct contact routes, requiring rigorous precautions. In institutional settings, respiratory and contact isolation should be implemented. Specific immunoglobulin may be considered for post-exposure prophylaxis in non-immune high-risk individuals, including pregnant women, newborns, and immunocompromised patients. Post-exposure vaccination in susceptible individuals, when administered within 3 to 5 days after exposure, can prevent or attenuate the disease.

Conclusion

Appropriate coding of chickenpox using ICD-11 code 1E90 is essential for accurate clinical documentation, effective epidemiological surveillance, and adequate management of public health resources. Detailed understanding of diagnostic criteria, specific clinical situations for code application, differentiation of related conditions, and appropriate documentation ensures quality of health data and facilitates analyses that inform public policies and clinical practices. Healthcare professionals should familiarize themselves with ICD-11 characteristics and apply this knowledge systematically to optimize patient care and contribute to robust and reliable health information systems.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Chickenpox

Compartilhar